Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD

138.6  +0.98 (+0.71%)

After market: 138.6 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LRN. LRN was compared to 71 industry peers in the Diversified Consumer Services industry. LRN gets an excellent profitability rating and is at the same time showing great financial health properties. LRN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make LRN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year LRN was profitable.
LRN had a positive operating cash flow in the past year.
Each year in the past 5 years LRN has been profitable.
Each year in the past 5 years LRN had a positive operating cash flow.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.56%, LRN belongs to the top of the industry, outperforming 90.14% of the companies in the same industry.
The Return On Equity of LRN (21.12%) is better than 87.32% of its industry peers.
LRN has a better Return On Invested Capital (14.55%) than 92.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LRN is in line with the industry average of 10.64%.
The last Return On Invested Capital (14.55%) for LRN is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROIC 14.55%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 13.10%, LRN belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
LRN's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 16.49%, LRN belongs to the best of the industry, outperforming 80.28% of the companies in the same industry.
LRN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 39.08%, LRN is in line with its industry, outperforming 46.48% of the companies in the same industry.
In the last couple of years the Gross Margin of LRN has grown nicely.
Industry RankSector Rank
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LRN is still creating some value.
LRN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LRN has been increased compared to 5 years ago.
The debt/assets ratio for LRN has been reduced compared to a year ago.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.36 indicates that LRN is not in any danger for bankruptcy at the moment.
LRN has a better Altman-Z score (7.36) than 87.32% of its industry peers.
LRN has a debt to FCF ratio of 2.09. This is a good value and a sign of high solvency as LRN would need 2.09 years to pay back of all of its debts.
LRN has a better Debt to FCF ratio (2.09) than 78.87% of its industry peers.
LRN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
LRN's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. LRN outperforms 45.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Altman-Z 7.36
ROIC/WACC1.73
WACC8.43%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

LRN has a Current Ratio of 5.61. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.61, LRN belongs to the best of the industry, outperforming 92.96% of the companies in the same industry.
LRN has a Quick Ratio of 5.53. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
LRN has a better Quick ratio (5.53) than 92.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.61
Quick Ratio 5.53
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.47% over the past year.
LRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 39.31% yearly.
LRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.90%.
LRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.97% yearly.
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%

3.2 Future

Based on estimates for the next years, LRN will show a very strong growth in Earnings Per Share. The EPS will grow by 21.50% on average per year.
The Revenue is expected to grow by 10.82% on average over the next years. This is quite good.
EPS Next Y44.56%
EPS Next 2Y26.61%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue Next Year16.8%
Revenue Next 2Y12.49%
Revenue Next 3Y11.03%
Revenue Next 5Y10.82%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.62, which indicates a rather expensive current valuation of LRN.
69.01% of the companies in the same industry are more expensive than LRN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LRN to the average of the S&P500 Index (27.45), we can say LRN is valued slightly cheaper.
The Price/Forward Earnings ratio is 18.52, which indicates a rather expensive current valuation of LRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 69.01% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. LRN is around the same levels.
Industry RankSector Rank
PE 21.62
Fwd PE 18.52
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 70.42% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LRN is valued a bit cheaper than the industry average as 67.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.63
EV/EBITDA 11.49
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LRN may justify a higher PE ratio.
A more expensive valuation may be justified as LRN's earnings are expected to grow with 21.50% in the coming years.
PEG (NY)0.49
PEG (5Y)0.55
EPS Next 2Y26.61%
EPS Next 3Y21.5%

0

5. Dividend

5.1 Amount

LRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STRIDE INC

NYSE:LRN (7/3/2025, 7:45:17 PM)

After market: 138.6 0 (0%)

138.6

+0.98 (+0.71%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners112.37%
Inst Owner Change-2.33%
Ins Owners2.68%
Ins Owner Change-0.36%
Market Cap6.03B
Analysts83.64
Price Target165.71 (19.56%)
Short Float %9.46%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.39%
Min EPS beat(2)-0.5%
Max EPS beat(2)3.28%
EPS beat(4)3
Avg EPS beat(4)86.24%
Min EPS beat(4)-0.5%
Max EPS beat(4)331.54%
EPS beat(8)7
Avg EPS beat(8)64.82%
EPS beat(12)10
Avg EPS beat(12)21.41%
EPS beat(16)13
Avg EPS beat(16)22.68%
Revenue beat(2)2
Avg Revenue beat(2)2.53%
Min Revenue beat(2)2.13%
Max Revenue beat(2)2.93%
Revenue beat(4)4
Avg Revenue beat(4)3.46%
Min Revenue beat(4)0.58%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)3.08%
Revenue beat(12)11
Avg Revenue beat(12)3.02%
Revenue beat(16)15
Avg Revenue beat(16)3.24%
PT rev (1m)0.91%
PT rev (3m)21.24%
EPS NQ rev (1m)6.34%
EPS NQ rev (3m)7.39%
EPS NY rev (1m)1.68%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)0.76%
Revenue NQ rev (3m)3.2%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.48%
Valuation
Industry RankSector Rank
PE 21.62
Fwd PE 18.52
P/S 2.64
P/FCF 24.63
P/OCF 19.67
P/B 4.26
P/tB 6.12
EV/EBITDA 11.49
EPS(TTM)6.41
EY4.62%
EPS(NY)7.49
Fwd EY5.4%
FCF(TTM)5.63
FCFY4.06%
OCF(TTM)7.05
OCFY5.08%
SpS52.52
BVpS32.57
TBVpS22.64
PEG (NY)0.49
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROCE 19.44%
ROIC 14.55%
ROICexc 23.21%
ROICexgc 36.04%
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
FCFM 10.71%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
ROICexc(3y)14.4%
ROICexc(5y)11.23%
ROICexgc(3y)26.36%
ROICexgc(5y)21.09%
ROCE(3y)12.66%
ROCE(5y)10.14%
ROICexcg growth 3Y21.6%
ROICexcg growth 5Y11.49%
ROICexc growth 3Y26.37%
ROICexc growth 5Y16.18%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
F-Score7
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Debt/EBITDA 0.96
Cap/Depr 54.87%
Cap/Sales 2.7%
Interest Coverage 42.95
Cash Conversion 62.64%
Profit Quality 81.78%
Current Ratio 5.61
Quick Ratio 5.53
Altman-Z 7.36
F-Score7
WACC8.43%
ROIC/WACC1.73
Cap/Depr(3y)62.27%
Cap/Depr(5y)61.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.69%
Profit Quality(3y)114.31%
Profit Quality(5y)120.41%
High Growth Momentum
Growth
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
EPS Next Y44.56%
EPS Next 2Y26.61%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%
Revenue Next Year16.8%
Revenue Next 2Y12.49%
Revenue Next 3Y11.03%
Revenue Next 5Y10.82%
EBIT growth 1Y63.97%
EBIT growth 3Y31.23%
EBIT growth 5Y40.56%
EBIT Next Year102.61%
EBIT Next 3Y35.59%
EBIT Next 5Y25.2%
FCF growth 1Y51.48%
FCF growth 3Y38.43%
FCF growth 5Y18.44%
OCF growth 1Y32.37%
OCF growth 3Y27.61%
OCF growth 5Y14.51%